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Abstract 
Stroke is one of the leading causes of disability and death. Most often, stroke results from blockage of 
an artery in the brain leading to tissue infarction within the perfusion territory of the affected vessel. 
Despite the severity of the insult, many cells are not irreversibly damaged within the first few hours 
and can be rescued by early restoration of blood flow or other interventions. Astrocytes, the most 
numerous cells in the brain, normally perform many functions that are essential for neuronal viability. 
Thus, stimulation of key astrocytic properties in ischemic or post-ischemic brain could potentially 
contribute to neuroprotection. However, at present, there is very little understanding of either the 
response of astrocytes to cerebral ischemia or the extent to which these cells can recover function if 
blood flow is restored.    
 
The main aim of the project was to assess key metabolic properties in astrocytes during early 
reperfusion following unilateral occlusion of the middle cerebral artery (MCA) in rats. Astrocytic 
oxidative metabolism was assessed from the incorporation of radiolabel from [1-14C]acetate into 
glutamine, an activity that is essentially specific for these cells. Striatal tissue from the hemisphere 
subjected to ischemia showed substantial decreases in 14C-glutamine production at 1 hour of 
reperfusion following either 2 or 3 hours of ischemia.  In contrast, this activity was almost fully 
preserved for at least 4 hours in parts of the cerebral cortex that had been subjected to more moderate 
ischemia, even when the duration of ischemia was sufficient to induce infarction in this region. The 
production of 14C-glutamine was also not significantly affected in cortical tissue exposed to more 
severe ischemia but this measure was much more variable between animals. These findings 
demonstrate regional differences in the response of astrocytes to focal ischemia and provide evidence 
that most cortical astrocytes remain viable and metabolically active for many hours, even in tissue 
destined to become infarcted.  
 
To further evaluate metabolic recovery in the post-ischemic brain, the production of 14C-glutamate and 
14C-glutamine from [U-14C]glucose was assessed. Neurons are responsible for most of the 14C-
glutamate generation whereas 14C-glutamine is produced in astrocytes from glutamate of neuronal and 
astrocytic origin.  Marked reductions in the labeling of both amino acids were observed in all regions 
of the MCA territory during early reperfusion after either 2 or 3 h ischemia irrespective of whether the 
tissue would become infarcted. These results provide evidence for widespread depression of glucose 
metabolism in neurons and altered metabolic interactions with astrocytes. Interestingly, this reduction 
in glucose metabolism was not associated with substantial changes in tissue phosphocreatine content 
and ATP:ADP ratio suggesting that energy requirements were reduced by the ischemia-reperfusion.   
 
Increases in lactate content were detected during early reperfusion in tissue regions that would develop 
infarcts. This finding coupled with previous evidence for deleterious effects of lactic acid suggests that 
accumulation of this metabolite might promote cell death. An impairment of pyruvate oxidation or 
reduced clearance of lactate could contribute to the increased lactate. The mechanisms by which 
excess lactate is cleared from the brain are not known. We hypothesized that MCT4 is involved in the 
removal of lactate as this transporter isoform is responsible for lactate export from other tissues. Using 
immunogold cytochemistry, MCT4 was found to be densely expressed in the endfeet of glial cells 
facing blood capillaries and pial surface of the brain, suggesting an important role in the removal of 
excess lactate from the CNS. In future studies, the expression of MCT4 will be examined following 
ischemia to resolve whether an altered expression of this transporter may be one reason for the 
elevated lactate levels in the brain. 
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